The pseudouridine epitranscriptomic landscape of advanced prostate cancer therapeutic resistance identifies TIMM17A as a key player
Shu Li, Chuanfan Zhong, Yixun Zhang, Guo Chen, Le Zhang, Jiahong Chen, Ronghua Yang · 2026
Read The pseudouridine epitranscriptomic landscape of advanced prostate cancer therapeutic resistance identifies TIMM17A as a key player by Shu Li, Chuanfan Zhong, Yixun Zhang, Guo Chen, Le Zhang, Jiahong Chen, Ronghua Yang (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13564067.txt.
Description
Shu Li and co-authors map, in 2026, a chemical mark on RNA in prostate cancer that has stopped responding to hormone-blocking drugs. Resistance to these drugs is a major barrier in advanced disease, and RNA marks are a growing focus in cancer biology. The team built a resistant cell model and profiled both gene activity and the mark's placement.
Resistant cells showed wide changes in both measures, and higher marking generally tracked higher gene activity. One gene stood out as a driver: it was raised in tumors, linked to worse outlook, and its levels promoted growth and resistance. Silencing it restored drug sensitivity in cells and in mice.
Catalog record
| CREATOR | Shu Li, Chuanfan Zhong, Yixun Zhang, Guo Chen, Le Zhang, Jiahong Chen, Ronghua Yang |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 53 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |